Back to News
Market Impact: 0.1
Kratom and 7-OH Now Half of QuickMD's New Addiction Patients, Up 5x as Federal Restrictions Loom
Source: Newswire
Healthcare & Biotech
One in two new addiction-treatment patients now seeks help for kratom or 7-OH. Most report prior opioid use, while half have never received buprenorphine treatment.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- Artiva halts AlloNK development, cuts 94% of workforce
- Universal Health Services falls 3% on legal settlement concerns
- Midterm elections: How affordability and the economy could impact voters
- adar1 capital management buys $53,691 of NextCure stock
- Zura Bio shares jump on Wedbush buy call ahead of trial data
- Why is Artiva Biotherapeutics stock collapsing today?